Literature DB >> 23454755

Control of inflammation by integration of environmental cues by regulatory T cells.

Ashutosh Chaudhry1, Alexander Y Rudensky.   

Abstract

Tregs have been implicated in control of homeostasis in the immune system and beyond. These cells restrain inflammatory responses to self antigens, commensal microorganisms, allergens, and pathogens and adapt their homeostatic and functional capabilities to a particular environment. In this review, we discuss a general model of integration of environmental cues by Tregs in which specialized Treg homeostatic, migratory, and suppression programs are established in dynamically changing inflammatory environments by maintaining an optimal threshold of activation of transcription factors involved in regulation of the corresponding type of effector immune responses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23454755      PMCID: PMC3582113          DOI: 10.1172/JCI57175

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

1.  Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3.

Authors:  Luke M Williams; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2007-01-14       Impact factor: 25.606

2.  Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE).

Authors:  T Matsuyama; A Grossman; H W Mittrücker; D P Siderovski; F Kiefer; T Kawakami; C D Richardson; T Taniguchi; S K Yoshinaga; T W Mak
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

3.  The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells.

Authors:  W Zheng; R A Flavell
Journal:  Cell       Date:  1997-05-16       Impact factor: 41.582

4.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Authors:  Ivaylo I Ivanov; Brent S McKenzie; Liang Zhou; Carlos E Tadokoro; Alice Lepelley; Juan J Lafaille; Daniel J Cua; Dan R Littman
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

5.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

6.  Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses.

Authors:  Jinfang Zhu; Booki Min; Jane Hu-Li; Cynthia J Watson; Alex Grinberg; Qi Wang; Nigel Killeen; Joseph F Urban; Liying Guo; William E Paul
Journal:  Nat Immunol       Date:  2004-10-10       Impact factor: 25.606

7.  Transcriptional regulation of th2 differentiation by inducible costimulator.

Authors:  Roza I Nurieva; Julie Duong; Hiroko Kishikawa; Umberto Dianzani; Jose M Rojo; I cheng Ho; Richard A Flavell; Chen Dong
Journal:  Immunity       Date:  2003-06       Impact factor: 31.745

8.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

Review 9.  Interleukin-17 family and IL-17 receptors.

Authors:  T A Moseley; D R Haudenschild; L Rose; A H Reddi
Journal:  Cytokine Growth Factor Rev       Date:  2003-04       Impact factor: 7.638

10.  IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo.

Authors:  Birgit Sawitzki; Cherry I Kingsley; Vanessa Oliveira; Mahzuz Karim; Manuela Herber; Kathryn J Wood
Journal:  J Exp Med       Date:  2005-06-20       Impact factor: 14.307

View more
  94 in total

1.  Regulatory T cells use "Itch" to control asthma.

Authors:  WanJun Chen
Journal:  J Clin Invest       Date:  2013-10-25       Impact factor: 14.808

2.  ILC3-derived OX40L is essential for homeostasis of intestinal Tregs in immunodeficient mice.

Authors:  Tian Deng; Caixia Suo; Jiali Chang; Rui Yang; Jingyu Li; Ting Cai; Ju Qiu
Journal:  Cell Mol Immunol       Date:  2019-02-13       Impact factor: 11.530

3.  S1PR1 is crucial for accumulation of regulatory T cells in tumors via STAT3.

Authors:  Saul J Priceman; Shudan Shen; Lin Wang; Jiehui Deng; Chanyu Yue; Maciej Kujawski; Hua Yu
Journal:  Cell Rep       Date:  2014-03-13       Impact factor: 9.423

4.  Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function.

Authors:  Amit Saxena; Marcin Dobaczewski; Vikrant Rai; Zaffar Haque; Wei Chen; Na Li; Nikolaos G Frangogiannis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-08-15       Impact factor: 4.733

Review 5.  Restoring host-microbe homeostasis via selective chemoattraction of Tregs.

Authors:  G P Garlet; C S Sfeir; S R Little
Journal:  J Dent Res       Date:  2014-07-23       Impact factor: 6.116

Review 6.  Harnessing FOXP3+ regulatory T cells for transplantation tolerance.

Authors:  Herman Waldmann; Robert Hilbrands; Duncan Howie; Stephen Cobbold
Journal:  J Clin Invest       Date:  2014-04-01       Impact factor: 14.808

Review 7.  Impact of infection on transplantation tolerance.

Authors:  Shuangjin Yu; Chang Su; Xunrong Luo
Journal:  Immunol Rev       Date:  2019-09-19       Impact factor: 12.988

8.  The Physiological Role of Tumor Necrosis Factor in Human Immunity and Its Potential Implications in Spinal Manipulative Therapy: A Narrative Literature Review.

Authors:  Liang Zhang; Chao Hua Yao
Journal:  J Chiropr Med       Date:  2016-05-26

9.  Natural T Regulatory Cells (n Treg) in the Peripheral Blood of Healthy Subjects and Subjects with Chronic Periodontitis - A Pilot Study.

Authors:  Ram Sabarish; Suresh Ranga Rao; Vamsi Lavu
Journal:  J Clin Diagn Res       Date:  2016-03-01

Review 10.  Immunity, inflammation, and cancer: an eternal fight between good and evil.

Authors:  Shabnam Shalapour; Michael Karin
Journal:  J Clin Invest       Date:  2015-09-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.